|
|
John P. Atkinson, Michael M. Frank
J Clin Invest. 2006;
116(5):1215
doi:10.1172/JCI28622
Abstract |
Full text
| PDF

L
ectins like mannan-binding protein are part of the innate immune system. They circulate in association with serine proteases. Upon binding oligosaccharides, they activate the complement cascade analogous to the more familiar but evolutionarily more recent classical pathway, which is triggered by antibody binding to antigen. In this issue of the JCI, Selander et al. developed a sensitive and specific ELISA employing Salmonella-specific sugars to assess the activity of the lectin pathway of complement activation (see the related article beginning on page 1425). This more physiologic assay system allowed the investigators to rigorously define the requirements for lectin pathway activation. Furthermore, they uncovered an unsuspected means for this pathway to reach the desired critical step of activation of the opsonin C3. These types of functional assays will eventually replace the more laborious, less physiologic, and less informative approaches currently in use to monitor complement activation.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(17)
| Title and authors |
Publication |
Year |
DAF/CD55 and Protectin/CD59 modulate adaptive immunity and disease outcome in experimental autoimmune myasthenia gravis
Jindrich Soltys, Jose A. Halperin, Qin Xuebin
|
Journal of Neuroimmunology
|
2012 |
Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury.
Wilhelm J Schwaeble, Nicholas J Lynch, James E Clark, Michael Marber, Nilesh J Samani, Youssif Mohammed Ali, Thomas Dudler, Brian Parent, Karl Lhotta, Russell Wallis, Conrad A Farrar, Steven Sacks, Haekyung Lee, Ming Zhang, Daisuke Iwaki, Minoru Takahashi, Teizo Fujita, Clark E Tedford, Cordula M Stover
|
Proc. Natl. Acad. Sci. U.S.A.
|
2011 |
Complement system and the brain: Selected pathologies and avenues toward engineering of neurological nanomedicines
S.M. Moghimi, B. Lettiero, A.J. Andersen, A.C. Hunter
|
Journal of Controlled Release
|
2011 |
Virus–complement interactions: an assiduous struggle for dominance
Kalyani Pyaram, Viveka Nand Yadav, Malik Johid Reza, Arvind Sahu
|
Future Virology
|
2010 |
Innate immunity as orchestrator of stem cell mobilization
M Z Ratajczak, C H Kim, W Wojakowski, A Janowska-Wieczorek, M Kucia, J Ratajczak
|
Leukemia
|
2010 |
Complement: a key system for immune surveillance and homeostasis
Daniel Ricklin, George Hajishengallis, Kun Yang, John D Lambris
|
Nat Immunol
|
2010 |
Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo
S. S. Seregin, Y. A. Aldhamen, D. M. Appledorn, Z. C. Hartman, N. J. Schuldt, J. Scott, S. Godbehere, H. Jiang, M. M. Frank, A. Amalfitano
|
Blood
|
2010 |
Therapeutic potential of complement modulation
Eric Wagner, Michael M. Frank
|
Nat Rev Drug Discov
|
2009 |
The complement system in the peripheral nerve: Friend or foe?
V. Ramaglia, M.R. Daha, F. Baas
|
Molecular Immunology
|
2008 |
Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: Functional and structural correlates
Emanuela Pappalardo, Sonia Caccia, Chiara Suffritti, Attila Tordai, Lorenza Chiara Zingale, Marco Cicardi
|
Molecular Immunology
|
2008 |
|